{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:52:16Z","timestamp":1781513536524,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41433-026-04295-6","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:13:33Z","timestamp":1776064413000},"page":"1393-1398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Secondary extraocular extension of choroidal melanoma following primary photodynamic therapy"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6632-6044","authenticated-orcid":false,"given":"Nadeem","family":"Atwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep S.","family":"Mudhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-0922","authenticated-orcid":false,"given":"Paul","family":"Cauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-7459","authenticated-orcid":false,"given":"Umiya","family":"Harley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rundle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-3168","authenticated-orcid":false,"given":"Hibba","family":"Quhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"4295_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","volume":"110","author":"A Singh","year":"2003","unstructured":"Singh A, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003;110:956\u201361.","journal-title":"Ophthalmology"},{"key":"4295_CR2","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/cncr.20866","volume":"103","author":"CC McLaughlin","year":"2005","unstructured":"McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103:1000\u20137.","journal-title":"Cancer"},{"key":"4295_CR3","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.ophtha.2012.01.048","volume":"119","author":"EM Damato","year":"2012","unstructured":"Damato EM, Damato BE. Detection and Time to Treatment of Uveal Melanoma in the United Kingdom: An Evaluation of 2384 Patients. Ophthalmology. 2012;119:1582\u20139.","journal-title":"Ophthalmology"},{"key":"4295_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/OPTH.S89591","volume":"11","author":"BA Krantz","year":"2017","unstructured":"Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD. Uveal melanoma: Epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol. 2017;11:279\u201389.","journal-title":"Clin Ophthalmol"},{"key":"4295_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118:1881\u20135. https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.040.","journal-title":"Ophthalmology"},{"key":"4295_CR6","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.ejca.2015.07.013","volume":"51","author":"P Nathan","year":"2015","unstructured":"Nathan P, Cohen V, Coupland S, Curtis K, Damato B, Evans J, et al. Uveal Melanoma UK National Guidelines. Eur J Cancer. 2015;51:2404\u201312.","journal-title":"Eur J Cancer"},{"key":"4295_CR7","volume-title":"Uveal melanoma : biology and management","author":"AC Schefler","year":"2021","unstructured":"Schefler AC, Bernicker EH Uveal melanoma : biology and management. 1st ed. Cham, Switzerland: Springer; 2021.","edition":"1st ed"},{"key":"4295_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s43856-022-00082-y","volume":"2","author":"G St\u00e5lhammar","year":"2022","unstructured":"St\u00e5lhammar G, Herrspiegel C. Long-term relative survival in uveal melanoma: a systematic review and meta-analysis. Commun Med. 2022;2:18.","journal-title":"Commun Med"},{"key":"4295_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.preteyeres.2011.05.003","volume":"30","author":"B Damato","year":"2011","unstructured":"Damato B, Eleuteri A, Taktak AFG, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30:285\u201395.","journal-title":"Prog Retin Eye Res"},{"key":"4295_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0301-4738.154367","volume":"63","author":"S Kaliki","year":"2015","unstructured":"Kaliki S, Shields C, Shields J. Uveal melanoma: Estimating prognosis. Indian J Ophthalmol. 2015;63:93\u2013102.","journal-title":"Indian J Ophthalmol"},{"key":"4295_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.bjc.6605765","volume":"103","author":"B Damato","year":"2010","unstructured":"Damato B. Does ocular treatment of uveal melanoma influence survival?. Br J Cancer. 2010;103:285\u201390.","journal-title":"Br J Cancer"},{"key":"4295_CR12","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3390\/cancers13092267","volume":"13","author":"RN Hussain","year":"2021","unstructured":"Hussain RN, Coupland SE, Kalirai H, Taktak AFG, Eleuteri A, Damato BE, et al. Small High-Risk Uveal Melanomas Have a Lower Mortality Rate. Cancers. 2021;13:2267 https:\/\/doi.org\/10.3390\/cancers13092267.","journal-title":"Cancers"},{"key":"4295_CR13","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1111\/aos.14847","volume":"99","author":"I Smidt-Nielsen","year":"2021","unstructured":"Smidt-Nielsen I, Bagger M, Heegaard S, Andersen KK, Kiilgaard JF. Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70-year nationwide cohort. Acta Ophthalmol. 2021;99:e1474\u2013e1482. https:\/\/doi.org\/10.1111\/aos.14847.","journal-title":"Acta Ophthalmol"},{"key":"4295_CR14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/bjophthalmol-2020-316616","volume":"105","author":"H Quhill","year":"2021","unstructured":"Quhill H, Gosling D, Sears K, Rundle P. Primary photodynamic therapy for small amelanotic choroidal melanomas: consecutive case series of 69 patients with at least 24-month follow-up. Br J Ophthalmol. 2021;105:794\u20139.","journal-title":"Br J Ophthalmol"},{"key":"4295_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/biomedicines6010017","volume":"6","author":"MA Blasi","year":"2018","unstructured":"Blasi MA, Pagliara MM, Lanza A, Sammarco MG, Caputo CG, Grimaldi G, et al. Photodynamic therapy in ocular oncology. Biomedicines. 2018;6:17.","journal-title":"Biomedicines"},{"key":"4295_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","volume":"123","author":"BL Gallie","year":"2016","unstructured":"Gallie BL, Simpson ER, Saakyan S, Amiryan A, Valskiy V, Finger PT, et al. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma. Ophthalmology. 2016;123:86\u201391.","journal-title":"Ophthalmology"},{"key":"4295_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.survophthal.2022.05.002","volume":"68","author":"A Maheshwari","year":"2023","unstructured":"Maheshwari A, Finger PT. Laser treatment for choroidal melanoma: Current concepts. Surv Ophthalmol. 2023;68:211\u201324.","journal-title":"Surv Ophthalmol"},{"key":"4295_CR18","unstructured":"DeVita VT, Rosenberg SA, Lawrence TS. DeVita, Hellman, and Rosenberg\u2019s Cancer. United States: Wolters Kluwer; 2018. 1900-9."},{"key":"4295_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/s0002-9394(02)02171-2","volume":"135","author":"RA Zaldivar","year":"2003","unstructured":"Zaldivar RA, Aaberg TM, Sternberg PD, Waldron R, Grossniklaus HE. Clinicopathologic findings in choroidal melanomas after failed transpupillary thermotherapy. Am J Ophthalmol. 2003;135:657\u201363. https:\/\/doi.org\/10.1016\/s0002-9394(02)02171-2.","journal-title":"Am J Ophthalmol"},{"key":"4295_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ophtha.2014.09.029","volume":"122","author":"A Mashayekhi","year":"2015","unstructured":"Mashayekhi A, Shields CL, Rishi P, Atalay HT, Pellegrini M, McLaughlin JP, et al. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: Importance of risk factors in tumor control. Ophthalmology. 2015;122:600\u20139.","journal-title":"Ophthalmology"},{"key":"4295_CR21","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1001\/archopht.1980.01020040827006","volume":"98","author":"JC Affeldt","year":"1980","unstructured":"Affeldt JC, Minckler DS, Azen SP, Yeh L. Prognosis in Uveal Melanoma With Extrascleral Extension. Arch Ophthalmol. 1980;98:1975\u20139. https:\/\/doi.org\/10.1001\/archopht.1980.01020040827006.","journal-title":"Arch Ophthalmol"},{"key":"4295_CR22","first-page":"4245","volume":"54","author":"J van Beek","year":"2013","unstructured":"van Beek J, Koopmans A, Vaarwater J, de Klein A, Verdijk R, Kilic E, et al. Extraocular extension in uveal melanoma. Investig Ophthalmol Vis Sci. 2013;54:4245.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4295_CR23","first-page":"43","volume":"100","author":"ES Gragoudas","year":"2002","unstructured":"Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W, Augsburger JJ. Long-term risk of local failure after proton therapy for choroidal\/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002;100:43\u20139.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"4295_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000501971","volume":"6","author":"M Modorati Giulio","year":"2020","unstructured":"Modorati Giulio M, Dagan R, Mikkelsen Lauge H, Andreasen S, Ferlito A, Bandello F. Gamma Knife Radiosurgery for Uveal Melanoma: A Retrospective Review of Clinical Complications in a Tertiary Referral Center. Ocul Oncol Pathol. 2020;6:115\u201322.","journal-title":"Ocul Oncol Pathol"},{"key":"4295_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2017.01.024","volume":"177","author":"CMD Bellerive","year":"2017","unstructured":"Bellerive CMD, Aziz HAMD, Bena JMS, Wilkinson AP, Suh JHMD, Plesec TMD, et al. Local Failure after Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors and Management. Am J Ophthalmol. 2017;177:9\u201316.","journal-title":"Am J Ophthalmol"},{"key":"4295_CR26","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Group ToARMDWPTS","year":"1999","unstructured":"Group ToARMDWPTS. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin: One-Year Results of 2 Randomized Clinical Trials\u2014TAP Report 1. Arch Ophthalmol. 1999;117:1329\u201345.","journal-title":"Arch Ophthalmol"},{"key":"4295_CR27","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0161-6420(02)01059-X","volume":"109","author":"UM Schmidt-Erfurth","year":"2002","unstructured":"Schmidt-Erfurth UM, Kusserow C, Barbazetto IA, Laqua H. Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology. 2002;109:1256\u201366.","journal-title":"Ophthalmology"},{"key":"4295_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.oret.2020.08.019","volume":"5","author":"KA Roelofs","year":"2021","unstructured":"Roelofs KA, Fabian ID, Arora AK, Cohen VML, Sagoo MS. Long-term Outcomes of Small Pigmented Choroidal Melanoma Treated with Primary Photodynamic Therapy. Ophthalmol Retin. 2021;5:468\u201378.","journal-title":"Ophthalmol Retin"},{"key":"4295_CR29","first-page":"871","volume":"36","author":"VH Gonzalez","year":"1995","unstructured":"Gonzalez VH, Hu LK, Theodossiadis PG, Flotte TJ, Gragoudas ES, Young LH. Photodynamic therapy of pigmented choroidal melanomas. Invest Ophthalmol Vis Sci. 1995;36:871\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4295_CR30","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/S0161-6420(96)30391-6","volume":"103","author":"RY Kim","year":"1996","unstructured":"Kim RY, Hu L-K, Foster BS, Gragoudas ES, Young LHY. Photodynamic Therapy of Pigmented Choroidal Melanomas of Greater than 3-mm Thickness. Ophthalmology. 1996;103:2029\u201336.","journal-title":"Ophthalmology"},{"key":"4295_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/eye.2017.22","volume":"31","author":"ID Fabian","year":"2017","unstructured":"Fabian ID, Stacey AW, Papastefanou V, Al Harby L, Arora AK, Sagoo MS, et al. Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma. Eye. 2017;31:519\u201328.","journal-title":"Eye"},{"key":"4295_CR32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.survophthal.2020.09.006","volume":"66","author":"S Yordi","year":"2021","unstructured":"Yordi S, Soto H, Bowen RC, Singh AD. Photodynamic therapy for choroidal melanoma: What is the response rate?. Surv Ophthalmol. 2021;66:552\u20139.","journal-title":"Surv Ophthalmol"},{"key":"4295_CR33","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/bjophthalmol-2012-302490","volume":"97","author":"MY Chang","year":"2013","unstructured":"Chang MY, McCannel TA. Local treatment failure after globe-conserving therapy for choroidal melanoma. Br J Ophthalmol. 2013;97:804\u201311.","journal-title":"Br J Ophthalmol"},{"key":"4295_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10103-012-1052-0","volume":"28","author":"SK Houston","year":"2013","unstructured":"Houston SK, Wykoff CC, Berrocal AM, Hess DJ, Murray TG. Lasers for the treatment of intraocular tumors. Lasers Med Sci. 2013;28:1025\u201334.","journal-title":"Lasers Med Sci"},{"key":"4295_CR35","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1097\/IAE.0b013e31825097c1","volume":"32","author":"I Canal-Fontcuberta","year":"2012","unstructured":"Canal-Fontcuberta I, Salom\u00e3o DR, Robertson D, Cantrill HL, Koozekanani D, Rath PP, et al. Clinical and histopathologic findings after photodynamic therapy of choroidal melanoma. Retina. 2012;32:942\u20138.","journal-title":"Retina"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04295-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:54:42Z","timestamp":1781510082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04295-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4295"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04295-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. VC and HQ are Eye editorial board members.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}